Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06886152 · ClinicalTrials.gov registry record · NA
Spinal Stimulation and Gait Training to Improve Mobility in TBI
A NA study, sponsored by Kessler Foundation.
- Not yet
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT06886152: Clinical Trial NA study, sponsored by Kessler Foundation.
NCT06886152 is a NA study that has not yet begun recruiting, run by Kessler Foundation. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06886152, a NA study, has not yet begun recruiting, sponsored by Kessler Foundation.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this research study is to assess the effects of receiving transcutaneous spinal stimulation while performing walking exercises compared to completing walking exercises without spinal stimulation for individuals with hemiplegic TBI.
Primary Outcome
10 meter walk test is a timed test to evaluate walking speed after TBI and in response to the intervention.
Interventions
- OTHER Sham
- PROCEDURE Transcutaneous Spinal Cord Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2028-09-01 |
| Phase | NA |
What is known before NCT06886152 opens enrollment
NCT06886152 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT06886152 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06886152 about?
NCT06886152 is a clinical study titled "Spinal Stimulation and Gait Training to Improve Mobility in TBI". The purpose of this research study is to assess the effects of receiving transcutaneous spinal stimulation while performing walking exercises compared to completing walking exercises without spinal stimulation for individuals with hemiplegic TBI.
What is the current status of trial NCT06886152?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-09-01. Estimated completion is 2028-09-01.
What interventions are being tested in trial NCT06886152?
The interventions under investigation include: Sham (OTHER), Transcutaneous Spinal Cord Stimulation (PROCEDURE).
Who is sponsoring clinical trial NCT06886152?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06886152's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI